Abstract
Protection of gastrointestinal tract and an evident anti-inflammatory effect have been shown by a pentadecapeptide BPC 157, a fragment of organoprotective gastric juice peptide (BPC) (ip/ig) in comparison with several reference standards in various ulcer models (pre-/co-/post-treatment). Since an effect on mucosal healing was also noted, the BPC 157 effect on healing of colon-colon anastomoses was further investigated.
Methods: Male Albino Wistar rats, 250 g body weight, were used for the experiments. Bursting pressure (mean±SEM, mmHg) was measured on postoperative days 2, 5, 7 and 10 using a previously described method. The rats were treated with BPC 157 (10 µg or 10 ng/kg) given either (a) immediately after colon resection and colon-colon anastomosis, (i) ig, (ii) ip or (iii) locally, and sacrificed 2, 5, 7 or 10 days thereafter, or (b) with an additional (iv) ig or (v) ip application, 24 h after first medication (sacrifice on postoperative day 2). Controls received an equivolume of saline (5 ml/kg).
Results: After single administration of BPC 157, a dose-dependent increase in bursting pressure and maximal bowel wall tension relative to control values was evident after 2 days. When applied repeatedly, BPC resulted in a relative increase after 2 days at the lower BPC 157 dosage as well. Taken together, these data indicate that, in accordance with its strong protective effect on gastrointestinal tract, BPC 157 could beneficially influence healing of colon-colon anastomoses, and this was confirmed microscopically, and increase bursting strength, particularly in the early postoperative period. Whether this will have clinical implications remains to be seen.
Keywords
- pentadecapeptide BPC 157
- peptide BPC
- colon-colon anastomosis
- increased healing
This is a preview of subscription content, access via your institution.
Buying options
Preview
Unable to display preview. Download preview PDF.
References
Thompson JC, Greeley GH, Rayford PL, Townsend CM. Gastrointestinal Endocrinology. New York, St. Louis, San Francisco: McGraw-Hill Book Company; 1987.
Kriger TD. Brain peptides: what, where, and why? Science. 1983;222:975–85.
Sikiric P, Petek M, Rotkvic I et al. Hypothesis: stomach stress response, diagnostic and therapeutic value - a new approach in organoprotection. Exp Clin Gastroenterol. 1991;1:15–16.
Sikiric P, Petek M, Rucman R et al. The significance of the gastroprotective effect of body protection compound (BPC): modulation by different procedures. In: Mózsik Gy, Pár Á, Csomós G et al., eds. Cell Injury and Protection in the Gastrointestinal Tract: From Basic Science to Clinical Perspectives. Budapest: Akadémiai Kiadó; 1992:89–98.
Sikiric P, Petek M, Rucman R et al. A new gastric juice peptide, BPC - an overview of stomach/stress/ organoprotection hypothesis and BPC beneficial effects. J Physiol (Paris). 1993;87:313–27.
Sikiric P, Rotkvic I, Mise S et al. Dopamine agents efficacy in peptic ulcer healing and relapse prevention - a further indication for importance of stomach dopamine in the stress organoprotection concept. In: Szabo S, Taché Y, Glavin G, eds. Neuroendocrinology of Gastrointestinal Ulceration: Hans Selye Symposia on Neuroendocrinology and Stress. Vol 2. New York: Plenum Publishing Corporation; 1995:221–30.
Sikiric P, Seiwerth S, Grabarevic Z et al. Hepatoprotective effect of BPC 157, 15-aminoacid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci. 1993;53:PL 291–6.
Sikiric P, Seiwerth S, Grabarevic Z et al. The beneficial effect of BPC 157, a 15 amino acid peptide BPC 157 fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sci. 1994;54:PL63–8.
Sikiric P, Gyires K, Seiwerth S et al. The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity. Inflammopharmacology. 1993;2:121–7.
Mózsik G, Sikiric P, Petek M. Preventing effect of body protective compound (BPC) on the development of ethanol and HCl-induced gastric mucosal injury. Exp Clin Gastroenterol. 1991;1:8790.
Bosnjak ZJ, Graf BM, Sikiric P, Stowe DF. Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J. 1994;8:Al29.
Veljaca M, Pllana R, Lesch CA, Sanchez B, Chan K, Guglietta A. Protective effect of BPC 157 on a rat model of colitis. Gastroenterology. 1994;106:789.
Veljaca M, Lech CA, Pllana R, Sanchez B, Chan K, Guglietta A. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther. 1994;272:417–22.
Paré W, Klucyznski JM. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp Clin Gastroenterol. 1992;2:234–6.
Jiborn H, Ahonen J, Zederfeld B. Healing of experimental colonic anastomoses. Am J Surg. 1978;136:587–94.
Matsuse S, Walser M. Healing of intestinal anastomoses in adrenalectomized rats given corticosteroids. Am J Physiol. 1992;263:R164–8.
Rousselot LM, Slattery JR. Immediate complication of surgery of the large intestine. Surg Clin North Am. 1964;44:397.
Goligher JC, Graham NG, de Dombal FT. Anastomotic dehiscence after anterior resection of rectum and sigmoid. Br J Surg. 1970;57:109.
Dunphy JE. The cut gut. Am J Surg. 1970;119:1.
Morgenstern L, Yaamkawa T, Ben-Shoshan M, Lippman H. Anastomotic leakage after low colonic anastomosis. Am J Surg. 1972;123:104.
Dunphy JE. Preoperative preparation of the colon and other factors affecting anastomostic healing. Cancer. 1971;28:181.
Hawley PR, Faulk WP, Hunt TK, Dunphy JE. Collagenase activity in the gastrointestinal tract. Br J Surg. 1970;57:896.
Hawley PR, Hunt TK, Dunphy JE. Etiology of colonic leaks. Proc R Soc Med. 1970;(Suppl)63:28.
Hunt TK, Hawley PR. Surgical judgement and colonic anastomoses. Dis Colon Rectum. 1969;12:167.
Veljaca M, Chan K, Guglietta A. Digestion of h-EGF, h-TGF alfa, and BPC 15 in human gastric juice. Pharmacol Res. 1995;31:70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Zoricic, I. et al. (1997). Pentadecapeptide BPC 157 Beneficially Influences the Healing of Colon—Colon Anastomoses in Rats. In: Mózsik, G., Nagy, L., Pár, A., Rainsford, K.D. (eds) Cell Injury and Protection in the Gastrointestinal Tract. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5392-8_25
Download citation
DOI: https://doi.org/10.1007/978-94-011-5392-8_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6268-8
Online ISBN: 978-94-011-5392-8
eBook Packages: Springer Book Archive